Goldwasser Meredith bought PRME
February 21, 2024 · Form 4 insider transaction
Goldwasser Meredith bought 90,498 shares of Prime Medicine, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
90,498
Price
$0.00
Total value
N/A
InsiderGoldwasser Meredith
Role—
CompanyPrime Medicine, Inc. (PRME)
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 21, 2024
Filing dateFebruary 23, 2024
Shares owned after90,498
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 21, 2024, subject to the Reporting Person's continued service on each such vesting date.